S&P 500 7,584.31 ▲ 30.63 (+0.41%) DOW 51,561.93 ▲ 874.86 (+1.73%) NASDAQ 26,830.96 â–ŧ 23.02 (-0.09%) US Markets Closed â€ĸ 03:31 AM ET

BIOE

Bio Essence Corporation

Price Chart
Latest Quote

$0.27

+0.00 (+0.00%)
Current Price
Previous Close $0.27
Open $0.30
Day High $0.30
Day Low $0.30
Volume 2,500
Fetched: 2026-06-05T07:31:49
Stock Information
Shares Outstanding 46.81M
Total Debt $1.57M
Cash Equivalents $36K
Revenue $2.38M
Net Income $1.31M
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Market Cap $12.83M
P/E Ratio 9.13
EPS (TTM) $0.03
Exchange OQB
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$14.35M
Sales$2.38M
Income$1.31M
Book/sh$-0.03
Cash/sh$0.00
Employees4
Financial Ratios
Quick Ratio0.02
Current Ratio0.36
Returns & Margins
ROA142.99%
Gross Margin72.69%
Operating Margin43.11%
Profit Margin55.02%
Ownership
Insider Ownership73.48%
Insider & Institutional transactions data not available
Valuation Ratios
P/S5.40
P/B-9.13
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.35
SMA50$0.35
SMA200$0.14
ATR0.0111
Shares Float16.89M
Volatility11.23
Performance History
Week+0.00%
Month-45.20%
Quarter+204.44%
6 Months+426.92%
YTD+356.67%
Year+19.13%
10 Years-39.11%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-03 $0.27 0
2026-06-02 $0.27 0
2026-06-01 $0.27 0
2026-05-29 $0.27 0
2026-05-28 $0.27 0
2026-05-27 $0.27 0
2026-05-26 $0.27 0
2026-05-22 $0.27 0
2026-05-21 $0.27 0
2026-05-20 $0.27 100
2026-05-19 $0.30 2,600
2026-05-18 $0.38 0
2026-05-15 $0.38 2,500
2026-05-14 $0.38 26,100
2026-05-13 $0.43 0
2026-05-12 $0.43 0
2026-05-11 $0.43 2,700
2026-05-08 $0.50 0
2026-05-07 $0.50 0
2026-05-06 $0.50 1,000
2026-05-05 $0.50 0
About Bio Essence Corporation

Bio Essence Corporation engages in manufacturing and distributing health supplement products. It also offers original equipment manufacturing, and private label services for dietary supplements, vitamins, and herbal nutrition products. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.

📰 Latest News
No news articles available at the moment. Check back later for updates on BIOE.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $106,863 $0 $293,264 $589,660
Cost Of Revenue $106,863 $0 $293,264 $589,660
Total Revenue $323,940 $0 $621,590 $887,984
Operating Revenue $323,940 $0 $621,590 $887,984
Expenses
Interest Expense $2,153 $2,197 $14,131 $38,558
Total Expenses $783,378 $345,590 $1,132,728 $1,736,896
Other Income Expense $-1,103,330 $-55,217 $4,980 $252,905
Other Non Operating Income Expenses $-52,390 $-55,217 $4,980 $261,520
Net Non Operating Interest Income Expense $-2,153 $-2,197 $-19,226 $-48,257
Interest Expense Non Operating $2,153 $2,197 $14,131 $38,558
Operating Expense $676,515 $345,590 $839,464 $1,147,236
Selling And Marketing Expense $0 $0 $76,318 $70,193
General And Administrative Expense $676,515 $345,590 $763,146 $1,077,043
Total Other Finance Cost - - $5,095 $9,699
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-1,565,721 $-404,604 $-527,884 $-647,564
Net Interest Income $-2,153 $-2,197 $-19,226 $-48,257
Normalized Income $-735,478 $-404,604 $-527,884 $-641,275
Net Income From Continuing And Discontinued Operation $-1,308,796 $-971,879 $-809,679 $-647,564
Total Operating Income As Reported $-459,438 $-345,590 $-511,138 $-857,527
Net Income Common Stockholders $-1,308,796 $-971,879 $-809,679 $-647,564
Net Income $-1,308,796 $-971,879 $-809,679 $-647,564
Net Income Including Noncontrolling Interests $-1,308,796 $-971,879 $-809,679 $-647,564
Net Income Discontinuous Operations $256,925 $-567,275 $-281,795 -
Net Income Continuous Operations $-1,565,721 $-404,604 $-527,884 $-647,564
Pretax Income $-1,564,921 $-403,004 $-525,384 $-644,264
Special Income Charges $-1,050,940 $0 $0 $-8,615
Operating Income $-459,438 $-345,590 $-511,138 $-848,912
Gross Profit $217,077 $0 $328,326 $298,324
Per Share
Diluted EPS $-0.03 $-0.03 $-0.02 $-0.02
Basic EPS $-0.03 $-0.03 $-0.02 $-0.02
Other
Tax Effect Of Unusual Items $-220,697 $0 $0 $-2,326
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-510,917 $-396,014 $-496,740 $-561,289
Total Unusual Items $-1,050,940 $0 $0 $-8,615
Total Unusual Items Excluding Goodwill $-1,050,940 $0 $0 $-8,615
Reconciled Depreciation $911 $4,793 $14,513 $35,802
EBITDA (Bullshit earnings) $-1,561,857 $-396,014 $-496,740 $-569,904
EBIT $-1,562,768 $-400,807 $-511,253 $-605,706
Diluted Average Shares $38,009,000 $33,954,205 $33,009,000 $33,009,000
Basic Average Shares $38,009,000 $33,954,205 $33,009,000 $33,009,000
Diluted NI Availto Com Stockholders $-1,308,796 $-971,879 $-809,679 $-647,564
Tax Provision $800 $1,600 $2,500 $3,300
Impairment Of Capital Assets $1,050,940 $0 - -
Selling General And Administration $676,515 $345,590 $839,464 $1,147,236
Other Gand A $676,515 $345,590 $763,146 $1,077,043
Write Off - - $0 $8,615
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-2,969,422 $-1,660,861 $-3,239,217 $-2,429,773
Total Assets $281,024 $2,758,580 $1,547,725 $1,699,221
Total Non Current Assets $332 $1,484,718 $1,343,894 $1,437,259
Non Current Prepaid Assets $0 $52,545 $41,841 $41,841
Goodwill And Other Intangible Assets $332 $567 $802 $1,037
Other Intangible Assets $332 $567 $802 $1,037
Current Assets $280,692 $1,273,862 $203,831 $261,962
Assets Held For Sale Current $0 $973,862 - -
Prepaid Assets $71,959 $0 $10,807 $31,870
Receivables $207,362 $300,000 $5,599 $16,820
Other Receivables $202,238 $300,000 - -
Accounts Receivable $5,124 $0 $5,599 $16,820
Cash Cash Equivalents And Short Term Investments $1,371 $0 $6,262 $303
Cash And Cash Equivalents $1,371 $0 $6,262 $303
Inventory - $143,259 $181,163 $212,969
Allowance For Doubtful Accounts Receivable - $-2,252 $-2,252 $-2,252
Gross Accounts Receivable - $37,345 $7,851 $19,072
Debt
Net Debt $1,241,287 $1,855,829 $3,451,592 $2,677,846
Total Debt $2,704,819 $3,289,455 $4,619,460 $3,962,783
Long Term Debt And Capital Lease Obligation $447,414 $991,529 $1,228,310 $1,371,993
Long Term Debt $55,124 $53,120 $235,867 $249,091
Current Debt And Capital Lease Obligation $2,257,405 $2,297,926 $3,391,150 $2,590,790
Current Debt $1,187,534 $1,802,709 $3,221,987 $2,429,058
Other Current Borrowings $1,187,534 $1,793,273 $3,168,336 $2,410,026
Liabilities
Total Liabilities Net Minority Interest $3,250,114 $4,418,874 $4,786,140 $4,127,957
Total Non Current Liabilities Net Minority Interest $447,414 $991,529 $1,228,310 $1,371,993
Current Liabilities $2,802,700 $3,427,345 $3,557,830 $2,755,964
Current Deferred Liabilities $187,115 $0 $45,612 $28,283
Payables And Accrued Expenses $358,180 $152,530 $121,068 $165,174
Interest Payable $2,306 $2,377 $16,867 $13,054
Payables $352,734 $12,453 $97,445 $75,011
Other Payable $256,741 $646,496 $39,277 $39,190
Accounts Payable $17,738 $12,453 $49,776 $62,583
Other Current Liabilities - $976,889 - $-50
Total Tax Payable - $6,909 $8,392 $12,428
Equity
Common Stock Equity $-2,969,090 $-1,660,294 $-3,238,415 $-2,428,736
Total Equity Gross Minority Interest $-2,969,090 $-1,660,294 $-3,238,415 $-2,428,736
Stockholders Equity $-2,969,090 $-1,660,294 $-3,238,415 $-2,428,736
Retained Earnings $-10,449,270 $-9,140,474 $-8,168,595 $-7,358,916
Other
Ordinary Shares Number $38,009,000 $38,009,000 $33,009,000 $33,009,000
Share Issued $38,009,000 $38,009,000 $33,009,000 $33,009,000
Tangible Book Value $-2,969,422 $-1,660,861 $-3,239,217 $-2,429,773
Invested Capital $-1,726,432 $195,535 $219,439 $249,413
Working Capital $-2,522,008 $-2,153,483 $-3,353,999 $-2,494,002
Capital Lease Obligations $1,462,161 $1,433,626 $1,161,606 $1,284,634
Total Capitalization $-2,913,966 $-1,607,174 $-3,002,548 $-2,179,645
Additional Paid In Capital $7,476,379 $7,476,379 $4,926,879 $4,926,879
Capital Stock $3,801 $3,801 $3,301 $3,301
Common Stock $3,801 $3,801 $3,301 $3,301
Preferred Stock $0 $0 $0 $0
Long Term Capital Lease Obligation $392,290 $938,409 $992,443 $1,122,902
Current Deferred Revenue $187,115 $0 $45,612 $28,283
Current Capital Lease Obligation $1,069,871 $495,217 $169,163 $161,732
Line Of Credit $0 $9,436 $53,651 $19,032
Current Accrued Expenses $5,446 $140,077 $23,623 $90,163
Dueto Related Parties Current $78,255 - - -
Net PPE $0 $1,431,606 $1,301,251 $1,394,381
Accumulated Depreciation $-56,505 $-56,431 $-216,929 $-163,187
Gross PPE $56,505 $1,488,037 $1,518,180 $1,557,568
Leases $0 $3,614 $57,067 $57,067
Machinery Furniture Equipment $56,505 $56,505 $406,241 $287,029
Properties $0 $0 $0 $0
Other Properties - $1,427,918 $1,054,872 $1,213,472
Inventories Adjustments Allowances - $-24,631 $-26,118 $-26,097
Finished Goods - $167,890 $146,576 $189,360
Raw Materials - $0 $60,705 $49,706
Non Current Accrued Expenses - - - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $623,865 $-1,029,287 $-706,983 $-1,413,614
Operating Activities
Operating Cash Flow $623,865 $-1,025,673 $-703,241 $-1,294,118
Cash From Discontinued Operating Activities $-15,952 $-44,214 $-206,646 -
Cash Flow From Continuing Operating Activities $639,817 $-981,459 $-496,595 $-1,294,118
Operating Gains Losses $3,012 $7,165 - $-1,089
Investing Activities
Investing Cash Flow $-114 $-91,484 $-59,120 $-116,796
Cash From Discontinued Investing Activities $0 $-87,870 $-55,378 -
Cash Flow From Continuing Investing Activities $-114 $-3,614 $-3,742 $-116,796
Capital Expenditure - $-3,614 $-3,742 $-119,496
Net Other Investing Changes - - - $-116,796
Financing Activities
Financing Cash Flow $-622,494 $1,111,009 $768,320 $1,405,892
Cash From Discontinued Financing Activities $-9,323 $-68,128 $-67,086 -
Cash Flow From Continuing Financing Activities $-613,171 $1,179,137 $835,406 $1,405,892
Other
Repayment Of Debt $-1,235 $-1,190 $-2,023 $-48,897
Interest Paid Supplemental Data $6,307 $23,809 $10,435 $38,558
Income Tax Paid Supplemental Data $800 $3,200 $3,300 $3,300
End Cash Position $1,371 $114 $6,262 $303
Beginning Cash Position $114 $6,262 $303 $5,325
Changes In Cash $1,257 $-6,148 $5,959 $-5,022
Net Issuance Payments Of Debt $-613,171 $1,179,137 $835,406 $1,405,892
Net Short Term Debt Issuance $-611,936 $1,180,327 $779,016 $1,240,914
Net Long Term Debt Issuance $-1,235 $-1,190 $56,390 $164,978
Long Term Debt Payments $-1,235 $-1,190 $-2,023 $-4,034
Net Business Purchase And Sale $-114 $0 - -
Purchase Of Business $-114 $0 - -
Net PPE Purchase And Sale $0 $-3,614 $-3,742 $-116,796
Purchase Of PPE $0 $-3,614 $-3,742 $-119,496
Change In Working Capital $865,990 $-71,640 $33,361 $-450,412
Change In Other Working Capital $187,115 - $-535 -
Change In Payables And Accrued Expense $205,651 $-22,770 $-3,675 $-504,438
Change In Accrued Expense $200,365 $-12,693 $14,454 $-506,101
Change In Interest Payable $-72 $-68 $7,171 $0
Change In Payable $5,286 $-10,077 $-18,129 $1,663
Change In Account Payable $5,286 $-10,077 $-15,130 $12,202
Change In Prepaid Assets $-24,358 $-52,545 $1,646 $-24,878
Change In Receivables $497,582 $3,675 $1,357 $19,641
Changes In Account Receivables $-5,124 $0 $1,357 $19,641
Other Non Cash Items $27,760 $50,102 $-16,585 $-239,470
Asset Impairment Charge $1,050,940 $0 $0 $8,615
Depreciation Amortization Depletion $911 $4,793 $14,513 $35,802
Depreciation And Amortization $911 $4,793 $14,513 $35,802
Depreciation $911 $4,558 $14,513 -
Gain Loss On Sale Of PPE $3,012 $7,165 $0 $-1,089
Net Income From Continuing Operations $-1,308,796 $-971,879 $-527,884 $-647,564
Issuance Of Debt - $1,170,891 $779,016 $1,454,789
Short Term Debt Payments - $-16,971 - $-44,863
Short Term Debt Issuance - $1,170,891 $779,016 $1,285,777
Change In Other Current Assets - $-52,545 $0 $59,263
Change In Tax Payable - $2,638 $-2,999 $-10,539
Change In Income Tax Payable - $2,638 $-2,999 $-10,539
Change In Inventory - $-10,090 $34,568 $59,263
Amortization Cash Flow - $235 - -
Amortization Of Intangibles - $235 - -
Long Term Debt Issuance - - $0 $169,012
Sale Of PPE - - $0 $2,700
Stock Based Compensation - - - $0
Provisionand Write Offof Assets - - - $8,615
Fetched: 2026-02-02